HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PTPN23
protein tyrosine phosphatase non-receptor type 23
Chromosome 3 Β· 3p21.31
NCBI Gene: 25930Ensembl: ENSG00000076201.17HGNC: HGNC:14406UniProt: B4DST5
109PubMed Papers
21Diseases
0Drugs
52Pathogenic Variants
FUNCTIONAL ROLE
Transporter
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein tyrosine phosphatase activityprotein bindingprotein kinase bindingnegative regulation of epithelial cell migrationneurodevelopmental disorder and structural brain anomalies with or without seizures and spasticityneurodegenerative diseaseGlobal developmental delayBrain atrophy
✦AI Summary

PTPN23 is a protein tyrosine phosphatase that functions as a multifaceted regulator of endosomal trafficking and cell survival. Primarily, PTPN23 coordinates with ESCRT-I complex machinery to sort ubiquitinated cargos into multivesicular bodies for degradation 12. Recent evidence reveals that PTPN23-dependent ESCRT machinery functions as a cell death checkpoint, regulating endosomal accumulation of death receptors and toll-like receptors to restrain apoptotic, necroptotic, and pyroptotic pathways 3. PTPN23 also mediates microautophagy of ubiquitylated tau aggregates through interaction with ESCRT-I and ESCRT-III complexes 4, while facilitating cardiac T-tubule formation by promoting dystrophin-glycoprotein complex assembly at costameres 5. Clinically, PTPN23 mutations cause neurodevelopmental disorders with structural brain anomalies, seizures, and spasticity 67. Loss of PTPN23 promotes proliferation and epithelial-to-mesenchymal transition in colorectal cancer through enhanced EGF signaling 8, establishing PTPN23 as a tumor suppressor 9. Additionally, PTPN23 activates PI3KC2Ξ± signaling to support BRAF-mutant melanoma cell survival, making it a therapeutic vulnerability 10. These findings position PTPN23 as critical for developmental integrity, cancer suppression, and cellular quality control.

Sources cited
1
PTPN23 interacts with ESCRT-I complex for sorting endocytic ubiquitinated cargos into MVBs
PMID: 18434552
2
PTPN23 role in ESCRT-I complex interaction for cargo sorting
PMID: 21757351
3
PTPN23-dependent ESCRT machinery acts as cell death checkpoint regulating death receptor and TLR endosomal accumulation
PMID: 39609437
4
PTPN23 bridges ESCRT-I and ESCRT-III for microautophagy of ubiquitylated tau aggregates
PMID: 40197510
5
PTPN23 promotes dystrophin-glycoprotein complex assembly and T-tubule formation in cardiac muscle
PMID: 38214189
6
PTPN23 mutations identified in neurogenetic disorders with brain anomalies and seizures
PMID: 25558065
7
PTPN23 variants validated as causative in neurodevelopmental and neurological disorders
PMID: 27848944
8
Loss of PTPN23 promotes proliferation and EMT in colorectal cancer through enhanced EGF signaling
PMID: 31768389
9
PTPN23/HD-PTP acts as haplo-insufficient tumor suppressor
PMID: 28620046
10
PTPN23 activates PI3KC2Ξ± signaling supporting BRAF-mutant melanoma survival
PMID: 39841180
Disease Associationsβ“˜21
neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticityOpen Targets
0.80Strong
neurodegenerative diseaseOpen Targets
0.46Moderate
Global developmental delayOpen Targets
0.41Moderate
Brain atrophyOpen Targets
0.41Moderate
Intellectual disabilityOpen Targets
0.37Weak
complex neurodevelopmental disorderOpen Targets
0.37Weak
liver diseaseOpen Targets
0.27Weak
hereditary spastic paraplegiaOpen Targets
0.26Weak
SeizureOpen Targets
0.26Weak
genetic disorderOpen Targets
0.19Weak
urinary bladder carcinomaOpen Targets
0.16Weak
Neurodevelopmental disorderOpen Targets
0.15Weak
neoplasmOpen Targets
0.08Suggestive
hepatocellular carcinomaOpen Targets
0.07Suggestive
breast cancerOpen Targets
0.07Suggestive
familial hypercholesterolemiaOpen Targets
0.05Suggestive
Familial exudative vitreoretinopathyOpen Targets
0.05Suggestive
goutOpen Targets
0.05Suggestive
acute myeloid leukemiaOpen Targets
0.05Suggestive
retinitis pigmentosaOpen Targets
0.05Suggestive
Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticityUniProt
Pathogenic Variants52
NM_015466.4(PTPN23):c.3040dup (p.Leu1014fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 1014
NM_015466.4(PTPN23):c.3581_3584del (p.Val1194fs)Pathogenic
Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 1194
NM_015466.4(PTPN23):c.1081_1082del (p.Val361fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 361
NM_015466.4(PTPN23):c.1837A>T (p.Lys613Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2026β†’ Residue 613
NM_015466.4(PTPN23):c.947dup (p.Asn316fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 316
NM_015466.4(PTPN23):c.3586C>T (p.Arg1196Ter)Pathogenic
Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity|not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 1196
NM_015466.4(PTPN23):c.2411_2418del (p.Gln804fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 804
NM_015466.4(PTPN23):c.3619C>T (p.Arg1207Ter)Likely pathogenic
Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity
β˜…β˜†β˜†β˜†2025β†’ Residue 1207
NM_015466.4(PTPN23):c.3208C>T (p.Arg1070Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 1070
NM_015466.4(PTPN23):c.3299dup (p.Ala1103fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 1103
NM_015466.4(PTPN23):c.1486C>T (p.Arg496Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 496
NM_015466.4(PTPN23):c.2199_2200del (p.Ser733fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 733
NM_015466.4(PTPN23):c.4121del (p.Val1374fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 1374
NM_015466.4(PTPN23):c.3582_3583del (p.Trp1195fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 1195
NM_015466.4(PTPN23):c.4317+1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2024
NM_015466.4(PTPN23):c.1002del (p.Gly335fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 335
NM_015466.4(PTPN23):c.2689_2696del (p.Pro897fs)Likely pathogenic
Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity
β˜…β˜†β˜†β˜†2024β†’ Residue 897
NM_015466.4(PTPN23):c.2249_2250del (p.Pro750fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 750
NM_015466.4(PTPN23):c.4074-1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2024
NM_015466.4(PTPN23):c.3113_3137dup (p.His1046fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 1046
View on ClinVar β†—
Related Genes
TSG101Protein interaction99%STAMProtein interaction99%HGSProtein interaction99%STAM2Protein interaction99%CHMP4BProtein interaction99%CHMP4CProtein interaction97%
Tissue Expression6 tissues
Ovary
100%
Lung
89%
Liver
73%
Bone Marrow
66%
Brain
55%
Heart
42%
Gene Interaction Network
Click a node to explore
PTPN23TSG101STAMHGSSTAM2CHMP4BCHMP4C
PROTEIN STRUCTURE
Preparing viewer…
PDB5MK2 Β· 1.70 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.58Moderately Constrained
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.48 [0.39–0.58]
RankingsWhere PTPN23 stands among ~20K protein-coding genes
  • #4,375of 20,598
    Most Researched109 Β· top quartile
  • #1,291of 5,498
    Most Pathogenic Variants52 Β· top quartile
  • #3,833of 17,882
    Most Constrained (LOEUF)0.58 Β· top quartile
Genes detectedPTPN23
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families.
PMID: 25558065
Cell Rep Β· 2015
1.00
2
Clinical exome sequencing: results from 2819 samples reflecting 1000 families.
PMID: 27848944
Eur J Hum Genet Β· 2017
0.90
3
PTPN23-dependent ESCRT machinery functions as a cell death checkpoint.
PMID: 39609437
Nat Commun Β· 2024
0.80
4
ESCRT-I and PTPN23 mediate microautophagy of ubiquitylated tau aggregates.
PMID: 40197510
J Cell Biol Β· 2025
0.70
5
Ptpn23 Controls Cardiac T-Tubule Patterning by Promoting the Assembly of Dystrophin-Glycoprotein Complex.
PMID: 38214189
Circulation Β· 2024
0.60